132 related articles for article (PubMed ID: 25367951)
21. Sumoylation of TCF21 downregulates the transcriptional activity of estrogen receptor-alpha.
Ao X; Li S; Xu Z; Yang Y; Chen M; Jiang X; Wu H
Oncotarget; 2016 May; 7(18):26220-34. PubMed ID: 27028856
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of estrogen receptor phosphorylation.
Murphy LC; Seekallu SV; Watson PH
Endocr Relat Cancer; 2011 Feb; 18(1):R1-14. PubMed ID: 21149515
[TBL] [Abstract][Full Text] [Related]
23. SPBP is a phosphoserine-specific repressor of estrogen receptor alpha.
Gburcik V; Bot N; Maggiolini M; Picard D
Mol Cell Biol; 2005 May; 25(9):3421-30. PubMed ID: 15831449
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of estrogen receptor α-36 by breast cancer oncogene IKKε promotes growth of ER-negative breast cancer cells.
Li Q; Sun H; Zou J; Ge C; Yu K; Cao Y; Hong Q
Cell Physiol Biochem; 2013; 31(6):833-41. PubMed ID: 23816933
[TBL] [Abstract][Full Text] [Related]
25. Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.
Xu Z; Yang Y; Li B; Li Y; Xia K; Yang Y; Li X; Wang M; Li S; Wu H
Cell Death Dis; 2018 May; 9(5):559. PubMed ID: 29752474
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Weitsman GE; Weebadda W; Ung K; Murphy LC
Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
[TBL] [Abstract][Full Text] [Related]
27. Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo.
Murphy LC; Weitsman GE; Skliris GP; Teh EM; Li L; Peng B; Davie JR; Ung K; Niu YL; Troup S; Tomes L; Watson PH
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):139-46. PubMed ID: 17092701
[TBL] [Abstract][Full Text] [Related]
28. Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development.
Nahorski MS; Maddirevula S; Ishimura R; Alsahli S; Brady AF; Begemann A; Mizushima T; Guzmán-Vega FJ; Obata M; Ichimura Y; Alsaif HS; Anazi S; Ibrahim N; Abdulwahab F; Hashem M; Monies D; Abouelhoda M; Meyer BF; Alfadhel M; Eyaid W; Zweier M; Steindl K; Rauch A; Arold ST; Woods CG; Komatsu M; Alkuraya FS
Brain; 2018 Jul; 141(7):1934-1945. PubMed ID: 29868776
[TBL] [Abstract][Full Text] [Related]
29. Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth.
Zhao J; Chen G; Cao D; Li Y; Diao F; Cai H; Jin Y; Lu J
Breast Cancer Res Treat; 2010 Jan; 119(1):39-51. PubMed ID: 19191023
[TBL] [Abstract][Full Text] [Related]
30. Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.
Saville B; Poukka H; Wormke M; Janne OA; Palvimo JJ; Stoner M; Samudio I; Safe S
J Biol Chem; 2002 Jan; 277(4):2485-97. PubMed ID: 11696545
[TBL] [Abstract][Full Text] [Related]
31. Small leucine zipper protein functions as a negative regulator of estrogen receptor α in breast cancer.
Jeong J; Park S; An HT; Kang M; Ko J
PLoS One; 2017; 12(6):e0180197. PubMed ID: 28662179
[TBL] [Abstract][Full Text] [Related]
32. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
33. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.
Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
Curr Drug Targets; 2019; 20(6):690-704. PubMed ID: 30324876
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
35. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.
Zhang F; Feng F; Yang P; Li Z; You J; Xie W; Gao X; Yang J
Int J Biochem Cell Biol; 2012 Feb; 44(2):320-6. PubMed ID: 22094188
[TBL] [Abstract][Full Text] [Related]
36. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
37. [Post-translational modifications modulate estrogen receptor alpha activity in breast tumors].
Poulard C; Bouchekioua-Bouzaghou K; Sentis S; Corbo L; Le Romancer M
Med Sci (Paris); 2010; 26(6-7):636-40. PubMed ID: 20619167
[TBL] [Abstract][Full Text] [Related]
38. PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression.
Citro S; Miccolo C; Meloni L; Chiocca S
J Mol Cell Biol; 2015 Apr; 7(2):132-42. PubMed ID: 25801958
[TBL] [Abstract][Full Text] [Related]
39. UFMylation: A Unique & Fashionable Modification for Life.
Wei Y; Xu X
Genomics Proteomics Bioinformatics; 2016 Jun; 14(3):140-146. PubMed ID: 27212118
[TBL] [Abstract][Full Text] [Related]
40. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
Ali A; Ielciu I; Alkreathy HM; Khan AA
Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
